![Henrik Harling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Henrik Harling served as the Chairman of the Danish Colorectal Cancer Group from 1994 to 2010.
He also worked as the Chief Medical Officer at 2cureX AB from 2019 to 2022.
Former positions of Henrik Harling
| Companies | Position | End |
|---|---|---|
| 2CUREX AB | Chief Tech/Sci/R&D Officer | 30/06/2022 |
Danish Colorectal Cancer Group | Chairman | 31/12/2009 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
2cureX AB
 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
Danish Colorectal Cancer Group |
- Stock Market
- Insiders
- Henrik Harling
